Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa

计划入组 1 人 · 首次发布于 2019 年 11 月 21 日

Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea

计划入组 60 人 · 首次发布于 2025 年 1 月 15 日

GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment

计划入组 9 人 · 首次发布于 2025 年 9 月 25 日

SASS-001

PFL-002

ACLX-002

BAYLOR SCOTT & WHITE RESEARCH INSTITUTE

United States

Odyssey Therapeutics

Eyenovia

United States

Apnimed Secures $150M from Shionogi Joint Venture Sale, Advances First-in-Class OSA Drug Toward FDA Submission

Pierre Fabre's PFL-002/VERT-002 Enters Phase I/II Trial for NSCLC with MET Alterations

Pierre Fabre's PFL-002/VERT-002 Enters Phase I/II Trial for NSCLC with MET Alterations